Eastwood Financial Statements From 2010 to 2024

Stocks . Canada . 
Stock . Eastwood Bio Medical Canada
EBM Stock  CAD 0.75  0.05  6.25%   
Eastwood Bio-Medical financial statements provide useful quarterly and yearly information to potential Eastwood Bio Medical Canada investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Eastwood Bio-Medical financial statements helps investors assess Eastwood Bio-Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Eastwood Bio-Medical's valuation are summarized below:
Gross Profit
902.7 K
Profit Margin
(0.74)
Market Capitalization
51.7 M
Enterprise Value Revenue
79.1323
Revenue
653.5 K
There are over one hundred nineteen available fundamental signals for Eastwood Bio Medical Canada, which can be analyzed over time and compared to other ratios. All traders should should verify Eastwood Bio-Medical's prevailing fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Market Cap is likely to drop to about 79.5 M in 2024. Enterprise Value is likely to drop to about 78.8 M in 2024

Eastwood Bio-Medical Total Revenue

907,555

Check Eastwood Bio-Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eastwood Bio-Medical's main balance sheet or income statement drivers, such as Interest Expense of 34 K, Selling General Administrative of 858.4 K or Selling And Marketing Expenses of 2.8 K, as well as many indicators such as Price To Sales Ratio of 116, Dividend Yield of 0.0 or Days Sales Outstanding of 48.53. Eastwood financial statements analysis is a perfect complement when working with Eastwood Bio-Medical Valuation or Volatility modules.
  
This module can also supplement various Eastwood Bio-Medical Technical models . Check out the analysis of Eastwood Bio-Medical Correlation against competitors.

Eastwood Bio-Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets418.2 K440.2 K2.2 M
Slightly volatile
Other Current Liabilities545.4 K1 M1.1 M
Slightly volatile
Total Current Liabilities605.1 K1.2 M1.2 M
Slightly volatile
Current Deferred Revenue87.3 K83.1 K30.9 K
Slightly volatile
Accounts Payable122.8 K117 K52.8 K
Slightly volatile
Cash15.8 K16.6 K654.5 K
Slightly volatile
Cash And Short Term Investments15.8 K16.6 K724.5 K
Slightly volatile
Net Receivables70.8 K74.5 K809.9 K
Slightly volatile
Common Stock Shares Outstanding71.5 M79.2 M64.1 M
Slightly volatile
Liabilities And Stockholders Equity418.2 K440.2 K2.2 M
Slightly volatile
Other Current Assets42.5 K44.8 K365.8 K
Slightly volatile
Total Liabilities611.6 K1.2 M1.2 M
Slightly volatile
Total Current Assets129.1 K135.9 K1.9 M
Slightly volatile
Common Stock4.7 M5.4 M3.8 M
Slightly volatile
Other Stockholder Equity7.6 K8.6 K9.3 K
Slightly volatile
Accumulated Other Comprehensive Income7.6 K8.6 K9.3 K
Slightly volatile
Inventory57.1 K93.9 K57 K
Slightly volatile
Property Plant And Equipment Net495.5 K388.9 K361.7 K
Slightly volatile
Capital Stock3.7 M4.2 M4.6 M
Slightly volatile
Short Term Debt18.9 K26.5 K12.4 K
Slightly volatile
Property Plant Equipment520.2 K512.9 K378.8 K
Slightly volatile
Other Assets31.7 K33.4 K263.7 K
Slightly volatile
Short and Long Term Debt Total38.5 K26.5 K27.6 K
Slightly volatile
Long Term Debt32.7 K40 K27 K
Slightly volatile
Property Plant And Equipment Gross915.9 K960.8 K843.3 K
Slightly volatile
Short and Long Term Debt49.2 K71.3 K34.2 K
Slightly volatile

Eastwood Bio-Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense34 K32.4 K14 K
Slightly volatile
Selling General Administrative858.4 K766.7 K748.4 K
Slightly volatile
Selling And Marketing Expenses2.8 K3 K45.2 K
Slightly volatile
Total Revenue907.6 K998.1 K809.5 K
Slightly volatile
Gross Profit439 K506.6 K410.2 K
Slightly volatile
Other Operating Expenses1.4 M1.6 M1.3 M
Slightly volatile
Cost Of Revenue468.5 K491.5 K399.3 K
Slightly volatile
Total Operating Expenses990.7 K1.1 M872.7 K
Slightly volatile
Reconciled Depreciation91.2 K124 K59.5 K
Slightly volatile

Eastwood Bio-Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock858.7 K966.1 K1.1 M
Slightly volatile
Begin Period Cash Flow34.1 K35.9 K655.1 K
Pretty Stable
End Period Cash Flow15.8 K16.6 K654.5 K
Slightly volatile
Depreciation70.2 K124 K58.1 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio116165132
Pretty Stable
Days Sales Outstanding48.5331.3449.925
Very volatile
Average Payables76.6 K72.9 K46.5 K
Slightly volatile
Capex To Depreciation0.00.00.3104
Slightly volatile
EV To Sales114165131
Pretty Stable
Payables Turnover3.433.6117.9577
Pretty Stable
Sales General And Administrative To Revenue0.620.960.7329
Slightly volatile
Average Inventory0.550.576.9 K
Very volatile
Capex To Revenue0.00.00.0116
Slightly volatile
Cash Per Share2.0E-42.0E-40.0115
Slightly volatile
Days Payables Outstanding11010561.5268
Pretty Stable
Current Ratio0.08940.094115.8233
Slightly volatile
Receivables Turnover11.4512.05171
Slightly volatile
Graham Number0.0620.04560.0508
Very volatile
Average Receivables40.6 K42.7 K94.2 K
Very volatile
Revenue Per Share0.0120.01040.0111
Very volatile
Interest Debt Per Share0.00120.00124.0E-4
Slightly volatile
Debt To Assets0.07220.110.0561
Slightly volatile
Operating Cycle58.6631.3459.8832
Very volatile
Days Of Payables Outstanding11010561.5268
Pretty Stable
Ebt Per Ebit1.061.351.2612
Very volatile
Quick Ratio0.08940.094115.6842
Slightly volatile
Cash Ratio0.01090.01158.4442
Slightly volatile
Days Of Sales Outstanding48.5331.3449.925
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.031.531.2149
Slightly volatile
Fixed Asset Turnover2.572.952.6259
Pretty Stable
Debt Ratio0.07220.110.0561
Slightly volatile
Price Sales Ratio116165132
Pretty Stable
Asset Turnover1.211.150.6915
Slightly volatile
Gross Profit Margin0.50.560.4973
Slightly volatile

Eastwood Bio-Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap79.5 M103.2 M89.4 M
Pretty Stable
Enterprise Value78.8 M103.2 M88.7 M
Pretty Stable

Eastwood Fundamental Market Drivers

Cash And Short Term Investments18.4 K

About Eastwood Bio-Medical Financial Statements

Eastwood Bio-Medical investors use historical fundamental indicators, such as Eastwood Bio-Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eastwood Bio-Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue83.1 K87.3 K
Total Revenue998.1 K907.6 K
Cost Of Revenue491.5 K468.5 K
Sales General And Administrative To Revenue 0.96  0.62 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(0.52)(0.55)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Eastwood Stock Analysis

When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY